Black LK - Search Results

1

Roehrborn CG, Black LK. Roehrborn CG, et al. Among authors: black lk. BJU Int. 2011 Sep;108(6):806-13. doi: 10.1111/j.1464-410X.2011.10365.x. BJU Int. 2011. PMID: 21884356 Review.

2

First-year costs of treating prostate cancer: estimates from SEER-Medicare data.

Roehrborn CG, Albertsen P, Stokes ME, Black L, Benedict A. Roehrborn CG, et al. Prostate Cancer Prostatic Dis. 2009;12(4):355-60. doi: 10.1038/pcan.2009.21. Epub 2009 May 26. Prostate Cancer Prostatic Dis. 2009. PMID: 19468284

3

Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial.

Roehrborn CG, Wilson TH, Black LK. Roehrborn CG, et al. Among authors: black lk. J Urol. 2012 May;187(5):1732-8. doi: 10.1016/j.juro.2011.12.083. Epub 2012 Mar 15. J Urol. 2012. PMID: 22425127 Clinical Trial.

4

Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data.

Stokes ME, Black L, Benedict A, Roehrborn CG, Albertsen P. Stokes ME, et al. Prostate Cancer Prostatic Dis. 2010 Sep;13(3):278-84. doi: 10.1038/pcan.2010.5. Epub 2010 Mar 9. Prostate Cancer Prostatic Dis. 2010. PMID: 20212521

5

Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.

Barkin J, Roehrborn CG, Siami P, Haillot O, Morrill B, Black L, Montorsi F; CombAT Study Group. Barkin J, et al. BJU Int. 2009 Apr;103(7):919-26. doi: 10.1111/j.1464-410X.2009.08196.x. Epub 2009 Feb 23. BJU Int. 2009. PMID: 19239460 Clinical Trial.

6

Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.

Roehrborn CG, Nickel JC, Andriole GL, Gagnier RP, Black L, Wilson TH, Rittmaster RS. Roehrborn CG, et al. Urology. 2011 Sep;78(3):641-6. doi: 10.1016/j.urology.2011.03.063. Epub 2011 Jul 20. Urology. 2011. PMID: 21764428 Clinical Trial.

7

Dutasteride significantly improves quality of life measures in patients with enlarged prostate.

O'Leary MP, Roehrborn CG, Black L. O'Leary MP, et al. Prostate Cancer Prostatic Dis. 2008;11(2):129-33. doi: 10.1038/sj.pcan.4500990. Epub 2007 Jun 26. Prostate Cancer Prostatic Dis. 2008. PMID: 17592479

8

Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.

Fourcade RO, Benedict A, Black LK, Stokes ME, Alcaraz A, Castro R. Fourcade RO, et al. Among authors: black lk. BJU Int. 2010 Jan;105(1):49-56. doi: 10.1111/j.1464-410X.2009.08716.x. BJU Int. 2010. PMID: 20132102

9

Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial.

Bjerklund Johansen TE, Baker TM, Black LK. Bjerklund Johansen TE, et al. Among authors: black lk. BJU Int. 2012 Mar;109(5):731-8. doi: 10.1111/j.1464-410X.2011.10511.x. Epub 2011 Sep 20. BJU Int. 2012. PMID: 21933326

10

Lifetime economic burden of prostate cancer.

Stokes ME, Ishak J, Proskorovsky I, Black LK, Huang Y. Stokes ME, et al. Among authors: black lk. BMC Health Serv Res. 2011 Dec 28;11:349. doi: 10.1186/1472-6963-11-349. BMC Health Serv Res. 2011. PMID: 22204308 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page